Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass
Steven P. Sedlis, Dan Lewis, Venki Paramesh(University of Arizona), Stuart B. Pett, Kodangudi B. Ramanathan, Sarah M. Vernon, Douglass A. Morrison(Southern Arizona VA Health Care System), Frederick G.P. Welt(Harvard University), Vladimir Birjiniuk, Jerome Sacks(Edward Hines, Jr. VA Hospital), David T. Booth(Google (United States)), LaWayne Miller, Edward Murphy, Charles Barbiere, Tamim Antakli, Stefan Kiesz, Gulshan K. Sethi(University of Arizona), Jeffrey D. Lorin, John C. Lucke, Jorge Saucedo, William G. Henderson(University of Colorado Denver), Herbert Ward, Mitchell W. Krucoff(Duke University), Frederick L. Grover(University of Colorado Denver), Sundeep Mediratta, Walter G. Wolfe(Duke University), Darryl S. Weiman
Cited by 115
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium
|European Heart Journal|2011|1.2k
Independent Association between Acute Renal Failure and Mortality following Cardiac Surgery
|The American Journal of Medicine|1998|1.2k
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document
|Circulation|2018|926
Adv. Drug Delivery Rev.
|Advanced Drug Delivery Reviews|1997|863